Novo Nordisk’s Semaglutide Achieves ‘Cardiodiabesity’ Label

 
• By Bridget Silverman
  
cardiovascular pills
• Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers